enGene Therapeutics ENGN
NASDAQ ENGN
$2.00 +0.05 (+2.56%)
At close: Sep 30, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Total Current Liabilities (2022 - 2026)

Updated

enGene Therapeutics (ENGN) posted Total Current Liabilities of $27.21 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 33.1% from $20.44 million a year earlier and up 26.6% from the prior quarter.

Analysis

enGene Therapeutics (ENGN) Total Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Total Current Liabilities came in at $31.98 million, up 118.1% from FY2024.

  • Annual Total Current Liabilities has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 84.4% (FY2022 to FY2025).
  • In prior fiscal years, enGene Therapeutics' Total Current Liabilities was $14.66 million in FY2024 (+178.9%), $5.26 million in FY2023 (+3.0%) and $5.1 million in FY2022.
  • Quarterly Total Current Liabilities has run from a low of $5.1 million in fiscal Q4 2022 to a high of $31.98 million in fiscal Q4 2025 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last eight quarters, with growth averaging 95.6% over the last eight quarters.
  • The year-over-year growth in Total Current Liabilities has ranged between 3.0% (fiscal Q4 2023) and 185.8% (fiscal Q2 2025) over the last five years.
  • According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $21.49 million (Q2 2026), $24.61 million (Q1 2026) and $31.98 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 enGene Therapeutics 134.03 Mn 134.03 Mn - 27.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 27.21 Mn
Apr 30, 2026 21.49 Mn
Jan 31, 2026 24.61 Mn
Oct 31, 2025 31.98 Mn
Jul 31, 2025 20.44 Mn
Apr 30, 2025 18.00 Mn
Jan 31, 2025 12.96 Mn
Oct 31, 2024 14.66 Mn
Jul 31, 2024 13.46 Mn
Apr 30, 2024 6.30 Mn
Jan 31, 2024 6.91 Mn
Oct 31, 2023 5.26 Mn
Oct 31, 2022 5.10 Mn
API Access

enGene Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ENGN&period=max&api_key=YOUR_API_KEY